EUCTR2006-002424-42-IT
Active, not recruiting
Not Applicable
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - ND
OSPEDALE SACRO CUORE-DON CALABRIA0 sites150 target enrollmentJune 5, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatments
- Sponsor
- OSPEDALE SACRO CUORE-DON CALABRIA
- Enrollment
- 150
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients with subfoveal CNV due to ARMD who did not respond to currently available treatments presenting enlargment of CNV, and or reduced VA 2\. 1 50 VA 4 10 3\. Patients with bilateral disease will receive the treatment only in one eye in order to evaluate the risks benefits. Only in case of benefit, the second eye will be treated.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\.Poor Blood Pressure control 2\.Previous Thromboembolic events, myocardial infarction, cerebral stroke. 3\.Pregnant women, or fertile age women who do not take the contraceptive pills 4\.Breast feeding women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of safety and efficacy on visual acuity outcome of intravitreal somministration of Bevacizumab in patients with diabetic retinopathy - NDDiabetic RetinopathyMedDRA version: 8.1Level: LLTClassification code 10012689Term: Diabetic retinopathyEUCTR2006-005315-10-ITOSPEDALE SACRO CUORE-DON CALABRIA
Not yet recruiting
Not Applicable
Clinical trial for visual function and safety evaluation:Artificial posterior capsule construction surgery and Intraocular lens implantation with 10-0 Polypropylene surgical suture which have been used for Scleral suture fixation of intraocular lensesaphakiaJPRN-UMIN000015145Yamaguchi university hospitalophthalmology20
Completed
Phase 2
Safety and effects on visual function of 0.01% atropine eye drops for myopia Inhibition in children and adolescentsH52.5Disorders of accommodationDRKS00020585niversitätsklinikum TübingenTübingen28
Active, not recruiting
Phase 1
Safety and effects on visual function of 0.01% Atropin eye drops for inhibition of nearsightedness in children and adolescenceMyopiaTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2017-002588-17-DEniversitätsklinikum Tübingen30
Completed
Not Applicable
Cataract Surgery(Phacoemulsification)Visual Acuity Outcome after Phacoemulsification between Diabetic and Non-Diabetic Patients.Cataract,Diabetic retinopathy,Visual acuity,phacoemulsification,cataract extractionTCTR20200610004Burapha University Hospital100